Vantage Consulting Group Inc - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 111 filers reported holding FIBROGEN INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
Vantage Consulting Group Inc ownership history of FIBROGEN INC
ValueSharesWeighting
Q3 2023$168,876
-68.0%
195,7070.0%0.11%
-62.8%
Q2 2023$528,409
-90.3%
195,707
-32.9%
0.30%
-90.2%
Q1 2023$5,443,253
-43.9%
291,707
-51.8%
3.09%
-46.0%
Q4 2022$9,703,522
+23.1%
605,7130.0%5.73%
+24.4%
Q3 2022$7,880,000
+23.2%
605,7130.0%4.60%
+28.4%
Q2 2022$6,396,000
-12.1%
605,713
+0.1%
3.59%
+26.2%
Q1 2022$7,280,000
-14.8%
605,173
-0.1%
2.84%
+23.7%
Q4 2021$8,541,000
+38.0%
605,7130.0%2.30%
+73.2%
Q3 2021$6,190,000
-61.6%
605,7130.0%1.33%
-52.7%
Q2 2021$16,130,000
-23.3%
605,7130.0%2.81%
-33.5%
Q1 2021$21,024,000
-6.4%
605,7130.0%4.22%
+130.7%
Q4 2020$22,465,000605,7131.83%
Other shareholders
FIBROGEN INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 305,784$8,143,0008.63%
Vantage Consulting Group Inc 605,713$16,130,0002.81%
GREAT POINT PARTNERS LLC 500,000$13,315,0002.79%
HHLR ADVISORS, LTD. 3,955,787$105,343,0001.08%
Intercontinental Wealth Advisors, LLC 191,300$5,094,0001.01%
Ikarian Capital, LLC 250,000$6,657,0000.54%
BHK Investment Advisors, LLC 45,100$1,201,0000.49%
Ikarian Capital, LLC 193,800$5,161,0000.42%
Omega Fund Management, LLC 130,646$3,479,0000.39%
Rhenman & Partners Asset Management AB 200,000$5,326,0000.36%
View complete list of FIBROGEN INC shareholders